Chrysin-piperazine conjugates as antioxidant and anticancer agents

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Chrysin, a natural flavonoid, possesses various biological activities but requires modification for enhanced therapeutic potential.
• Piperazine moieties are frequently incorporated into drug candidates to modulate pharmacokinetic and pharmacodynamic properties.

Purpose of the Study:

• To synthesize novel chrysin-piperazine derivatives and evaluate their antioxidant and anticancer properties.
• To investigate the structure-activity relationships of these synthesized compounds.

Main Methods:

• Synthesis of chrysin-piperazine derivatives via a 7-(4-bromobutoxy) intermediate.
• In vitro antioxidant assays using DPPH and ABTS free radical scavenging methods.
• In vitro anticancer activity evaluation against HeLa, CaSki (cervical), and SK-OV-3 (ovarian) cancer cell lines using SRB assay.
• Cytotoxicity assessment using Madin-Darby canine kidney (MDCK) cells and human bone marrow-derived mesenchymal stem cells (hBM-MSCs).

Main Results:

• The synthesized compounds (7a-w) demonstrated significant free radical scavenging activity, with analogs 7f, 7j, 7k, 7l, 7n, 7q, 7v, and 7w showing notable efficacy.
• Analogs 7j and 7o were highly active against HeLa and CaSki cell lines, while 7h, 7l, and 7j showed significant sensitivity towards the SKOV-3 ovarian cancer cell line.
• No cytotoxic effects were observed on hBM-MSCs, indicating a favorable safety profile.

Conclusions:

• Novel chrysin-piperazine derivatives exhibit promising antioxidant and anticancer activities.
• The substitution pattern on the piperazine core influences the observed biological activities.
• These compounds represent potential leads for developing new therapeutic agents against cancer.